Medpace Holdings Inc (MEDP)

Currency in USD
592.46
-14.14(-2.33%)
Closed·
597.65+5.19(+0.88%)
·
MEDP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
585.65604.48
52 wk Range
250.05626.26
Key Statistics
Prev. Close
606.6
Open
601.11
Day's Range
585.65-604.48
52 wk Range
250.05-626.26
Volume
203.47K
Average Volume (3m)
314.52K
1-Year Change
74.79%
Book Value / Share
10.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
538.25
Downside
-9.15%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Medpace Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Medpace Holdings Inc Company Profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings Inc Earnings Call Summary for Q3/2025

  • Q3 2025 EPS of $3.86 beat $3.53 forecast; revenue of $659.9M exceeded expectations, driving 7.91% stock surge to $621.41
  • Revenue grew 23.7% YoY to $659.9M; EBITDA up 24.9% to $148.4M; net income increased 15.3% to $111.1M
  • 2026 outlook: low double-digit revenue growth, high single-digit EBITDA growth; 2025 revenue projected at $2.48B-$2.53B
  • Strong performance in metabolic studies contributed to growth; Q3 net book-to-bill ratio of 1.20 indicates robust demand
  • CEO noted stable cancellations; CFO expects margins to remain strong in 2026, reinforcing positive outlook
Last Updated: 23/10/2025, 15:12
Read Full Transcript

Compare MEDP to Peers and Sector

Metrics to compare
MEDP
Peers
Sector
Relationship
P/E Ratio
38.5x−2.5x−0.6x
PEG Ratio
1.56−0.140.00
Price/Book
56.8x2.3x2.6x
Price / LTM Sales
7.1x2.7x3.3x
Upside (Analyst Target)
−6.4%9.8%38.7%
Fair Value Upside
Unlock6.9%3.2%Unlock

Analyst Ratings

1 Buy
8 Hold
4 Sell
Ratings:
13 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 538.25
(-9.15% Downside)

Earnings

Latest Release
Oct 22, 2025
EPS / Forecast
3.86 / 3.53
Revenue / Forecast
659.90M / 640.99M
EPS Revisions
Last 90 days

MEDP Income Statement

People Also Watch

163.33
WDC
+3.54%
61.47
FISV
+1.10%
976.94
FIX
+0.62%
47.810
IREN
-1.32%
73.12
CRWV
-1.57%

FAQ

What Is the Medpace Holdings (MEDP) Premarket Price Today?

The Medpace Holdings (MEDP) premarket price is 602.97. Premarket price change units: -3.63. Premarket percentage change: -0.60%. Premarket volume: 30.00. Current date: 29 Nov 2025. Previous close: 606.60

What Stock Exchange Does Medpace Holdings Trade On?

Medpace Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Medpace Holdings?

The stock symbol for Medpace Holdings is "MEDP."

What Is the Medpace Holdings (MEDP) Afterhours Price Today? (Afterhours variable test: 597.65) Current Date: 29 Nov 2025

After hours price: 597.65. After hours price change (units): 5.19. Price change percentage: 0.88%

What Is the Medpace Holdings Market Cap?

As of today, Medpace Holdings market cap is 16.69B.

What Is Medpace Holdings's Earnings Per Share (TTM)?

The Medpace Holdings EPS (TTM) is 14.32.

When Is the Next Medpace Holdings Earnings Date?

Medpace Holdings will release its next earnings report on 15 Feb 2026.

From a Technical Analysis Perspective, Is MEDP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Medpace Holdings Stock Split?

Medpace Holdings has split 0 times.

How Many Employees Does Medpace Holdings Have?

Medpace Holdings has 6200 employees.

What is the current trading status of Medpace Holdings (MEDP)?

As of 29 Nov 2025, Medpace Holdings (MEDP) is trading at a price of 592.46, with a previous close of 606.60. The stock has fluctuated within a day range of 585.65 to 604.48, while its 52-week range spans from 250.05 to 626.26.

What Is Medpace Holdings (MEDP) Price Target According to Analysts?

The average 12-month price target for Medpace Holdings is USD538.25, with a high estimate of USD655 and a low estimate of USD329. 1 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an -9.15% Downside potential.

What Is the MEDP Premarket Price?

MEDP's last pre-market stock price is 602.97. The pre-market share volume is 30.00, and the stock has decreased by -3.63, or -0.60%.

What Is the MEDP After Hours Price?

MEDP's last after hours stock price is 597.65, the stock has decreased by 5.19, or 0.88%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.